SNORA41: A Small Nucleolar RNA with Potential as a Drug Target or Biomarker

Target Name: SNORA41

NCBI ID: G619569

SNORA41

Other Name(s): small nucleolar RNA, H/ACA box 41 | Small nucleolar RNA, H/ACA box 41 | ACA41 | SNORA41A

SNORA41: A Small Nucleolar RNA with Potential as a Drug Target or Biomarker

Small nucleolar RNA (snRNA) is a non-coding RNA molecule that plays a critical role in the regulation of gene expression in the nucleus. One of the most well-known snRNAs is H/ACA box 41 (SNORA41), which is expressed in various tissues and cellular processes. In this article, we will discuss the potential implications of SNORA41 as a drug target or biomarker.

SNORA41: Structure and Function

SNORA41 is a 22-nt RNA molecule that contains a highly conserved H/ACA box (H/ACAbox) at its core. The H/ACA box is a common structural motif that is present in various snRNAs and is involved in the recognition of DNA-binding proteins. The H/ACA box is usually located at the base pairs 8-10 of the RNA molecule and is responsible for the formation of a base-pair with the AUG (methionine) at position 9.

SNORA41 has been shown to play a role in the regulation of gene expression in various organisms. For example, studies have shown that SNORA41 can interact with the protein Myb, which is involved in the regulation of DNA binding and gene expression. Additionally, SNORA41 has been shown to be involved in the regulation of cell cycle progression, and it has been shown to interact with the protein kinase A-Tanatake (ATN), which is involved in cell cycle progression and apoptosis.

Drug Target Potential

SNORA41 has been identified as a potential drug target due to its involvement in various cellular processes that are important for human health. For example, SNORA41 has been shown to be involved in the regulation of cell cycle progression, which is important for the development and progression of cancer. Additionally, SNORA41 has been shown to play a role in the regulation of gene expression, which is important for the development of various diseases.

Biomarker Potential

SNORA41 has also been identified as a potential biomarker for various diseases. For example, studies have shown that SNORA41 is downregulated in various cancer tissues and that it is involved in the regulation of cancer cell growth and survival. Additionally, studies have shown that SNORA41 is involved in the regulation of inflammation, and it has been shown to play a role in the development of various inflammatory diseases.

Conclusion

In conclusion, SNORA41 is a small nucleolar RNA that has been shown to play a critical role in the regulation of gene expression in various organisms. The potential implications of SNORA41 as a drug target or biomarker make it a promising target for research in various diseases. Further studies are needed to fully understand the role of SNORA41 in cellular processes and its potential as a drug or biomarker.

Protein Name: Small Nucleolar RNA, H/ACA Box 41

The "SNORA41 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNORA41 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets